| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.022 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.022 | 0 |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.742 | 1.922 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -720 | -1.922 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -781 | -1.922 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Pharma Services New Concept S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.915.575 | 2.885.840 | 2.837.007 | 2.784.943 | 2.731.009 | 2.679.235 | 2.619.821 | 2.627.949 | 2.619.969 | 0 |
| Current Assets | 1.675 | 1.658 | 1.630 | 1.600 | 1.569 | 1.539 | 1.505 | 1.510 | 796 | 18 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 10 |
| Cash | 1.670 | 1.653 | 1.625 | 1.596 | 1.565 | 1.535 | 1.501 | 1.506 | 792 | 8 |
| Shareholders Funds | 2.917.185 | 2.887.433 | 2.838.573 | 2.786.480 | 2.732.517 | 2.680.715 | 2.621.267 | 2.629.400 | 2.620.646 | -1.167 |
| Social Capital | 1.564 | 1.548 | 1.521 | 1.493 | 1.465 | 1.437 | 1.405 | 1.409 | 1.405 | 1.397 |
| Debts | 65 | 64 | 63 | 62 | 61 | 60 | 58 | 59 | 119 | 1.185 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8299 - 8299" | |||||||||
| CAEN Financial Year |
8299
|
|||||||||
Comments - Pharma Services New Concept S.r.l.